Sabra Healthcare (SBRA) Q4 2024 Annual Earnings
SBRA·Reported February 19, 2025·After market close
Sabra Healthcare reported Q4 2024 revenue of $182.3M, beat analyst consensus of $178.0M by $4.3M. Diluted EPS came in at $0.36.
Revenue
$182.3Mbeat by $4.3M
Consensus: $178.0MDiluted EPS
$0.36met estimate
Consensus: $0.36
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Sabra Healthcare's Q4 2024 earnings report.
Sabra Healthcare (SBRA) reported Q4 2024 earnings on February 19, 2025 after market close.
Sabra Healthcare reported revenue of $182.3M and diluted EPS of $0.36 for Q4 2024.
Revenue beat the consensus estimate of $178.0M by $4.3M. EPS beat the consensus estimate of $0.36 by $0.00.
You can read the 10-K periodic report (0001492298-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.